Literature DB >> 18667149

GABA(A)R plasticity during pregnancy: relevance to postpartum depression.

Jamie Maguire1, Istvan Mody.   

Abstract

Fluctuating neurosteroid levels over the ovarian cycle modulate neuronal excitability through effects on GABA(A) receptors (GABA(A)Rs). The large increase in progesterone-derived neurosteroids during pregnancy and their precipitous decline at parturition may have considerable effects on GABA(A)Rs during pregnancy and postpartum. Here we show a significant decrease in tonic and phasic inhibitions in pregnant mice, mediated by a downregulation of GABA(A)R delta and gamma2 subunits, respectively, which rebounds immediately postpartum. Mice which do not exhibit GABA(A)R delta subunit regulation throughout pregnancy (Gabrd(+/-) and Gabrd(-/-)) exhibit depression-like and abnormal maternal behaviors, resulting in reduced pup survival. These abnormal postpartum behaviors were ameliorated in Gabrd(+/-) mice by a GABA(A)R delta-subunit-selective agonist, THIP. We suggest that Gabrd(+/-) and Gabrd(-/-) mice constitute a mouse model of postpartum depression that may be useful for evaluating potential therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18667149      PMCID: PMC2875248          DOI: 10.1016/j.neuron.2008.06.019

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  35 in total

1.  Effects of gonadal steroids in women with a history of postpartum depression.

Authors:  M Bloch; P J Schmidt; M Danaceau; J Murphy; L Nieman; D R Rubinow
Journal:  Am J Psychiatry       Date:  2000-06       Impact factor: 18.112

2.  Gabapentin as a potential treatment for anxiety disorders.

Authors:  M H Pollack; J Matthews; E L Scott
Journal:  Am J Psychiatry       Date:  1998-07       Impact factor: 18.112

3.  Oxytocin is required for nursing but is not essential for parturition or reproductive behavior.

Authors:  K Nishimori; L J Young; Q Guo; Z Wang; T R Insel; M M Matzuk
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers.

Authors:  P Zwanzger; T C Baghai; C Schuele; A Ströhle; F Padberg; N Kathmann; M Schwarz; H J Möller; R Rupprecht
Journal:  Neuropsychopharmacology       Date:  2001-11       Impact factor: 7.853

5.  Noise analysis of miniature IPSCs in adult rat brain slices: properties and modulation of synaptic GABAA receptor channels.

Authors:  Y De Koninck; I Mody
Journal:  J Neurophysiol       Date:  1994-04       Impact factor: 2.714

6.  MDMA ("ecstasy") exhibits an anxiogenic-like activity in social encounters between male mice.

Authors:  E Maldonado; J F Navarro
Journal:  Pharmacol Res       Date:  2001-07       Impact factor: 7.658

7.  Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis.

Authors:  J Tiihonen; J Kuikka; P Räsänen; U Lepola; H Koponen; A Liuska; A Lehmusvaara; P Vainio; M Könönen; K Bergström; M Yu; I Kinnunen; K Akerman; J Karhu
Journal:  Mol Psychiatry       Date:  1997 Oct-Nov       Impact factor: 15.992

8.  Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine.

Authors:  V Uzunova; Y Sheline; J M Davis; A Rasmusson; D P Uzunov; E Costa; A Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

9.  Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study.

Authors:  A L Malizia; V J Cunningham; C J Bell; P F Liddle; T Jones; D J Nutt
Journal:  Arch Gen Psychiatry       Date:  1998-08

10.  Effects of antidepressant treatment on neuroactive steroids in major depression.

Authors:  E Romeo; A Ströhle; G Spalletta; F di Michele; B Hermann; F Holsboer; A Pasini; R Rupprecht
Journal:  Am J Psychiatry       Date:  1998-07       Impact factor: 18.112

View more
  174 in total

1.  γ-Aminobutyric acid type A (GABAA) receptor α subunits play a direct role in synaptic versus extrasynaptic targeting.

Authors:  Xia Wu; Zheng Wu; Gang Ning; Yao Guo; Rashid Ali; Robert L Macdonald; Angel L De Blas; Bernhard Luscher; Gong Chen
Journal:  J Biol Chem       Date:  2012-06-18       Impact factor: 5.157

2.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

3.  A tonic for anxiety.

Authors:  Tamás Füzesi; Jaideep S Bains
Journal:  Nat Neurosci       Date:  2015-10       Impact factor: 24.884

Review 4.  Neurosteroids: endogenous role in the human brain and therapeutic potentials.

Authors:  Doodipala Samba Reddy
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

Review 5.  GABAA receptor-mediated tonic depolarization in developing neural circuits.

Authors:  Juu-Chin Lu; Yu-Tien Hsiao; Chung-Wei Chiang; Chih-Tien Wang
Journal:  Mol Neurobiol       Date:  2013-09-11       Impact factor: 5.590

Review 6.  Using animal models to study post-partum psychiatric disorders.

Authors:  C V Perani; D A Slattery
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

7.  GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study.

Authors:  Kristina M Deligiannidis; Elif M Sikoglu; Scott A Shaffer; Blaise Frederick; Abby E Svenson; Andre Kopoyan; Chelsea A Kosma; Anthony J Rothschild; Constance M Moore
Journal:  J Psychiatr Res       Date:  2013-03-15       Impact factor: 4.791

Review 8.  An Emerging Circuit Pharmacology of GABAA Receptors.

Authors:  Elif Engin; Rebecca S Benham; Uwe Rudolph
Journal:  Trends Pharmacol Sci       Date:  2018-06-11       Impact factor: 14.819

Review 9.  Allopregnanolone and reproductive psychiatry: an overview.

Authors:  Katherine McEvoy; Lauren M Osborne
Journal:  Int Rev Psychiatry       Date:  2019-01-31

Review 10.  Promising leads and pitfalls: a review of dietary supplements and hormone treatments to prevent postpartum blues and postpartum depression.

Authors:  Yekta Dowlati; Jeffrey H Meyer
Journal:  Arch Womens Ment Health       Date:  2020-11-17       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.